AI evolution in Radiology and Space Medicine
Join us at CIC Cambridge for the February Dinner & Learn co-hosted by KASBP Boston Chapter and SpaceLiintech, part of our 2025–26 Dinner & Learn Series, where we’ll explore how AI is transforming radiology and advancing space medicine—from hospital imaging suites to the frontiers of human space exploration. Our speakers will share insights spanning real-world implementation of AI models in clinical radiology, next-generation medical imaging and diagnostics, and how space medicine research is leveraging advanced technologies and microgravity environments to transform drug development—from enabling novel biological discoveries to accelerating translational research. Together, we’ll discuss how innovations developed for Earth-based healthcare and space exploration are converging to shape the future of medicine.
Special thanks to SpaceLiinTech for their generous support in making this event possible!
Agenda
5:00 - 6:00 PM Check-in and Dinner
6:00 - 7:00 PM AI evolution in Radiology
"Radiology AI: Promise and Reality (From Lab to Adoption)"
Dr. Young H. Kim, MD, PhD, Professor, Radiology, UMass Chan Medical School
7:00 - 8:00 PM AI evolution in Space Medicine
"Space as a Biomedical Accelerator: AI-Enabled Medicine for Earth and Beyond "
Dr. Fathi Karouia, PhD, Senior Research Scientist, NASA Ames Research Center & Blue Marble Space Institute of Science
8:00 - 8:15 PM Sponsor Talk
Jeeyong Lee, Global Business Development Lead, SpaceLiinTech
8:15 - 9:00 PM Networking
About Speakers
Dr. Young H. Kim, MD, PhD, Professor of Radiology, UMass Chan Medical School — a clinician-scientist implementing AI models in medical imaging and pushing the frontiers of AI-driven radiology, from advanced image interpretation to next-generation diagnostic workflows.
Dr. Fathi Karouia, PhD, Senior Research Scientist, NASA Ames Research Center & Blue Marble Space Institute of Science — a leader in space biology and human spaceflight research, focusing on astronaut health, biomedical experimentation in space, and translational insights from space medicine back to Earth-based healthcare.
Jeeyong Lee, Global Business Development Lead at SpaceLiinTech, bringing over 22 years of global pharmaceutical and biotech experience—including leading 13 major product launches at Sanofi—to pioneer partnerships in space medicine and microgravity-enabled protein crystallization for next-generation drug discovery and biomanufacturing.
Abstract
"Radiology AI: Promise and Reality (From Lab to Adoption)"
This seminar will provide a practical overview of the current landscape of AI in radiology imaging and biomedical applications. Rather than focusing on technical details, the discussion will examine how current AI technologies are being adopted in real-world clinical and research settings. It will explore how AI innovations are perceived by practitioners, the gap between technological promise and operational reality, and the key challenges — including validation, trust, regulatory considerations, and workflow integration — that influence successful implementation. The goal is to offer a balanced perspective on where AI stands today and what is needed to translate innovation into meaningful real-world impact.
"Space as a Biomedical Accelerator: AI-Enabled Medicine for Earth and Beyond "
Space is rapidly emerging as a powerful biomedical accelerator rather than a distant frontier. The unique conditions of microgravity, radiation, and confinement reveal biological mechanisms that remain hidden on Earth, offering unprecedented opportunities to advance human health. This talk explores how space medicine—when combined with artificial intelligence—can accelerate discovery, de-risk innovation, and enable faster translation from biology to clinic. Drawing on real-world examples from spaceflight research, in-space manufacturing, and astronaut health, I will highlight how AI-driven analytics, digital twins, and multi-omics integration are transforming space-derived data into actionable medical insights. The presentation will also examine the growing commercial landscape at the intersection of space, biotech, and pharma, outlining near-term opportunities for drug development, precision medicine, and platform technologies that deliver value on Earth while enabling humanity’s expansion beyond it.